SCHEMBL417070

SCHEMBL417070

Oc1cccc(C2=CCCCC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 2/20 0.51
CHRNB4 P30926 1/20 0.49
CHRNA3 P32297 1/20 0.49
HSD17B1 P14061 6/20 0.47
HSD17B2 P37059 6/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 2/20 0.47
SERPINE1 P05121 1/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5269419 0.94 ACMSD (0.50) ACMSDCHRNB4CHRNA3HSD17B1HSD17B2
SCHEMBL9123640 0.84 HSD17B1 (0.54) CHRNB4CHRNA3HSD17B1HSD17B2CYP3A4
SCHEMBL28081447 0.84 ESR1 (0.55) ACMSDHSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL2032639 0.80 ACMSD (0.49) ACMSDSERPINE1MEN1KMT2AHDAC3
SCHEMBL11735637 0.79 ACMSD (0.47) ACMSDSERPINE1MEN1KMT2AHDAC3
SCHEMBL11741259 0.79 ACMSD (0.47) ACMSDSERPINE1MEN1KMT2AHDAC3
SCHEMBL11735644 0.79 ACMSD (0.47) ACMSDSERPINE1MEN1KMT2AHDAC3
SCHEMBL188943 0.78 MEN1 (0.55) ACMSDCYP3A4MEN1KMT2AHDAC3
SCHEMBL19910204 0.78 CHRNB4 (0.49) ACMSDCHRNB4CHRNA3SERPINE1TDP1
SCHEMBL11034153 0.78 CHRNB4 (0.49) ACMSDCHRNB4CHRNA3SERPINE1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2607348-B1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE INC (JP) 2021-03-17 EP disclosed
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO LTD (JP) 2014-10-02 US disclosed
US-8785473-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2014-07-22 US disclosed
EP-2607348-A2 Plasminogen Activator Inhibitor-1 Inhibitor Renascience CO., LTD. (JP) 2013-06-26 EP disclosed
EP-2415755-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Renascience CO., LTD. (JP) 2012-02-08 EP disclosed
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor RENASCIENCE CO., LTD. (JP) 2012-01-26 US disclosed
US-4914213-A Indole derivatives and process for producing the same FUJI PHOTO FILM CO., LTD. (JP) 1990-04-03 US disclosed
US-4707553-A Indole derivatives and process for producing the same FUJI PHOTO FILM CO., LTD. (JP) 1987-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296256-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ACMSD 4062/4885CHRNB4 4873/4885CHRNA3 4866/4885
US-20120022080-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 ACMSD 4062/4885CHRNB4 4873/4885CHRNA3 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.